NR4A1 and neoplasm: In contrast, hormonal receptor-positive patients had a median OS of 38 months (95% CI (33.9–45.6)) when having a histological Grade I or II tumor and a median OS of 31.8 months (95% CI (25.3–41.7)) for histological Grade III patients.